Back to top

InspireMD Stock Trades 20% Below Recent Insider Buy as NSPR Tests 52-Week Lows

InspireMD shares recently traded below insider purchase prices, including Director Paul Stuka's $0.88 buy on May 27, highlighting a 20% lower market entry. Multiple insiders bought in May, signaling conviction, yet the stock remains near its 52-week low, reflecting ongoing market uncertainty..

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

InspireMD, Inc. (NSPR)